Status: Recruiting
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
The goal of this clinical trial is to learn the safety of tumor neoantigen vaccine combined with neoantigen vaccine induced T-cell in treating advanced gastric cancer in adults. It will also learn if the combined treatment works to treat advanced gastric cancer. The main questions it aims to answer are: What medical problems do participants have when using the combined treatment? Does tumor neoantigen vaccine combined with neoantigen vaccine induced T-cell eliminate or shrink the tumor, and can it prolong the patient's survival period?
Participants needed: 18
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Jia WeiUpdated: Feb 25, 2026Locations: 1
Eligibility criteria
Provision of signed and dated informed consent form. [+5]
Requires long-term systemic administration of antiallergic drugs, or has severe... [+16]